On August 21, 2019, seven members of the board of directors of American BriVision (Holding) Corporation, which constituted a quorum and majority of the Board and acted throughout the meeting, held a board meeting via telephone to elect the officers of the company, among other things. All of the Board members present at the Meeting unanimously appointed Mr. Chihliang An as the Company’s Chief Financial Officer effective from September 1, 2019 for a term of three years. Mr. Chihliang An was the Managing Director of Investment Team at Yinyai Investment (Hong Kong) since September 2018 to June 2019. Prior to that, Mr. An served as a Senior Director of Sales and Operations at Goertek (USA) from March 2017 to August 2018 and a Director of Finance at BioKey Inc., which is a wholly-owned subsidiary of the Company now, from March 2015 to February 2017. Mr. Chihliang An received a Bachelor of Art degree in Statistics from Tamkang University in Taiwan in 2003 and an MBA in Finance from University of Kentucky in 2007.